Showing results (11-20 of 33) with videos related to
Sort By:
Pageof 4
Case Reports in Endocrinology|November 9, 2023
Coronary Artery and Peripheral Vascular Disease in a Patient with Poorly Differentiated Thyroid Cancer Treated with the Tyrosine Kinase Inhibitor LenvatinibVineeth Sukrithan, Lisa Kim, Jennifer A Sipos, et al.Annals of Surgical Oncology|August 5, 2025
Appendiceal Neuroendocrine Tumors: Prognostic Role of Mesoappendiceal Invasion and Implications for Recommending Right Hemicolectomy versus Simple AppendectomyDiamantis I Tsilimigras, Pamela Lu, Susan Tsai, et al.Journal of Clinical Epidemiology|July 19, 2015
Updated systematic review identifies substantial number of retention strategies: using more strategies retains more study participantsKaren A Robinson, Victor D Dinglas, Vineeth Sukrithan, et al.Case Reports in Endocrinology|June 14, 2021
Pembrolizumab in a Patient with Treatment-Naïve Unresectable BRAF-Mutation Negative Anaplastic Thyroid CancerFadi Nabhan, Elizabeth Kander, Rulong Shen, et al.Cancer Research|April 9, 2020
Targeted Inhibition of the E3 Ligase SCFSkp2/Cks1 Has Antitumor Activity in RB1-Deficient Human and Mouse Small-Cell Lung CancerHongling Zhao, Niloy J Iqbal, Vineeth Sukrithan, et al.Journal of Clinical Epidemiology|November 21, 2016
A systematic review finds limited data on measurement properties of instruments measuring outcomes in adult intensive care unit survivorsKaren A Robinson, Wesley E Davis, Victor D Dinglas, et al.The Lancet. Oncology|January 5, 2025
Pulmonary neuroendocrine neoplasms: the molecular landscape, therapeutic challenges, and diagnosis and management strategiesTriparna Sen, Yosuke Dotsu, Virginia Corbett, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 30, 2025
Whole-Exome Sequencing Reveals High Prevalence of Germline Alterations in Neuroendocrine NeoplasmsVineeth Sukrithan, Isaiah Boateng, Sandya Liyanarachchi, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 13, 2024
Trans-arterial embolization versus chemoembolization for neuroendocrine liver metastases: a propensity matched analysisSamantha M Ruff, Jin Y Chang, Menglin Xu, et al.Endocrine-Related Cancer|June 13, 2025
Targeting anti-apoptosis as a therapeutic strategy in neuroendocrine neoplasmsVineeth Sukrithan, Uzair Ahmed, Harris Krause, et al.Pageof 4